Ledger.Open graph →
SEC Form D · filed October 12, 2023

Iambic Therapeutics, Inc

Offering
$110.0M
Sold
$103.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Thomas Miller · San Diego, CAExec · DirectorChristina Blacker · Vancouver, British Columbia, CanadaExec · DirectorKurt Von Emster · San Diego, CADirectorJishnu Bhattacharjee · San Diego, CADirectorEvan Rachlin · San Diego, CADirectorSandra E. Mackay · Vancouver, British Columbia, CanadaDirectorFred Manby · San Diego, CAExec · DirectorChao Zhang · San Diego, CAExecFred Manby · San Diego, CAExec · DirectorJon Myers · Charlottesville, VADirectorWilliam Rastetter · San Diego, CADirectorThomas Miller · San Diego, CAExec · DirectorJohn R. Howard · Dallas, TXDirectorJishnu Bhattacharjee · San Diego, CADirectorWilliam Rastetter · San Diego, CADirectorTodd E. Hilditch · Vancouver, British Columbia, CanadaDirectorR. Jacob Vogelstein · San Diego, CADirectorDarcy E. Higgs · Vancouver, British Columbia, CanadaExec · DirectorKurt Von Emster · San Diego, CADirectorTabbert Teng · San Diego, CAExecChao Zhang · San Diego, CAExecTabbert Teng · San Diego, CAExecEvan Rachlin · San Diego, CADirectorR. Jacob Vogelstein · San Diego, CADirectorJohn E. E. Larson · Vancouver, British Columbia, CanadaExecPat S. Bolin · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗